ErvogaSTAT 是一种有效且耐受性良好的二酰基甘油酰基转移酶 2 抑制剂。 ErvogaSTAT 可降低非酒精性脂肪性肝炎 (NASH) 中的脂肪变性和肝脏甘油三酯水平。

Ervogastat is a potent and well-tolerated diacylglycerol acyltransferase 2 inhibitor. Ervogastat reduces steatosis and hepatic triglyceride levels in non-alcoholic steatohepatitis (NASH).

2186700-33-2

C21H21N5O4

407.43

PF-06865571

DMSO:120mg/ml(294.54mM),need ultrasonic
Powder: -20°C for 3 years
In solvent: -80°C for 2 years